CG Oncology Inc
NASDAQ:CGON
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
CG Oncology Inc
NASDAQ:CGON
|
US |
|
Etteplan Oyj
F:EPL
|
FI |
|
B
|
Bien Sparebank ASA
OSE:BIEN
|
NO |
|
Grown Rogue International Inc
OTC:GRUSF
|
US |
|
C
|
CSA Cosmic Co Ltd
KOSDAQ:083660
|
KR |
|
E
|
EMC PCL
SET:EMC
|
TH |
|
S
|
Space Hellas SA
ATHEX:SPACE
|
GR |
|
O
|
Omer SpA
MIL:OMER
|
IT |
|
O
|
Omni Inovasi Indonesia Tbk PT
IDX:TELE
|
ID |
|
F
|
Forth Smart Service PCL
SET:FSMART
|
TH |
|
T
|
T Man Pharmaceutical PCL
SET:TMAN
|
TH |
|
G
|
George Weston Ltd
OTC:WNGRF
|
CA |
|
Banca Profilo SpA
MIL:PRO
|
IT |
|
Societe BIC SA
PAR:BB
|
FR |
Intrinsic Value
Is CGON undervalued or overvalued?
See the intrinsic value estimate for CG Oncology Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
CGON looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with CGON’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What CG Oncology Does
CG Oncology is a biopharmaceutical company focused on treatments for bladder cancer. Its lead drug candidate is an engineered virus therapy designed to be placed directly into the bladder so it can attack cancer cells and stimulate the immune system. The company is still in the development stage, so its main product is a pipeline of experimental medicines rather than a broad commercial drug portfolio.
- Headquarters
- United States of America US
- Employees
- 142
- IPO date
- Jan 25, 2024
Earnings Waterfall
CG Oncology Inc
The intrinsic value for CG Oncology Inc (CGON) under the Base Case is hidden USD.
Compared with the current market price of 59.62 USD, the stock appears hidden.